Tin Tin Sandar

14PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 21, 2026
Breast Cancer Outcomes From Ductal Carcinoma In Situ: A Population-Based Cohort Study.

|Jul 07, 2025
Body mass index and breast cancer risk among postmenopausal women with and without cardiometabolic diseases: Findings from two prospective cohort studies in Europe.

Emma Fontvieille, Anna Jansana, Laia Peruchet-Noray

|Jun 11, 2025
Statin use and breast cancer-specific mortality and recurrence: a systematic review and meta-analysis including the role of immortal time bias and tumour characteristics.

Oliver William Scott, Sandar Tin Tin, Alana Cavadino

|Mar 03, 2025
Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study.

Phyu Sin Aye, Joanne Barnes, George Laking

|Aug 24, 2024
Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis.

Qian Chen, Ian Campbell, Mark Elwood

|Jul 02, 2024
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy.

Phyu Sin Aye, Joanne Barnes, George Laking

Pageof 3

Frequent Collaborators

4 joint publications

Mark Elwood

2 joint publications

George Laking

2 joint publications

Dean Harris

2 joint publications

Brendan Luey